In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer
Journal of Clinical Oncology · 10.12.2025 · 43 (35) · 3691-3697
DOI: 10.1200/jco-25-01440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.12.2025. Verfasst von Michelino De Laurentiis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale," Naples, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale," Naples, Italy.
- Clinical and Translational Oncology, Scuola Superiore Meridionale University, Naples, Italy.
ORCID-Profile: Michelino De Laurentiis
Zitieren
APA
De Laurentiis, M., Buonaiuto, R., Buono, G., Caputo, R., & De Angelis, C. (2025). In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer. Journal of Clinical Oncology, 43(35), 3691-3697. https://doi.org/10.1200/jco-25-01440
Vancouver
De Laurentiis M, Buonaiuto R, Buono G, Caputo R, De Angelis C. In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer. Journal of Clinical Oncology. 2025;43(35):3691-3697. doi:10.1200/jco-25-01440
BibTeX
@article{DeLaurentiis2025,
author = {De Laurentiis, Michelino and Buonaiuto, Roberto and Buono, Giuseppe and Caputo, Roberta and De Angelis, Carmine},
title = {In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer},
journal = {Journal of Clinical Oncology},
year = {2025},
volume = {43},
number = {35},
pages = {3691--3697},
doi = {10.1200/jco-25-01440}
}
EUVIMED